Literature DB >> 2177298

HIV screening during pregnancy. Results of 2 attitude surveys on antenatal HIV screening in Belgium.

M Denayer1, P Piot, T Jonckheer, A Stroobant.   

Abstract

Two postal questionnaires were sent to Belgian gynaecologists in order to have information on their current policy of antenatal HIV screening. Of the 815 contacted, 446 (54.7%) completed the first questionnaire. 91.0% offers HIV testing in pregnancy; 49.1% to all pregnant women and 41.9% only to those with behavioural risks. Only 6.5% never offers HIV testing during pregnancy. The majority of these gynaecologists (79.8%) never had to deal with the problem of HIV-seropositivity in a pregnant woman. A second questionnaire with more detailed questions about HIV testing was sent to the identified respondents of the first survey. 237 of 340 (69.7%) responded. Of those, 48.9% perform HIV testing without informing the patient, whereas 43.4% always inform their patients before HIV testing. The majority performs the test at the first antenatal consultation (73.5%; 14.9% offers the test twice. These findings let us conclude that there is a need for recommendations concerning the policy of antenatal screening and information of patients.

Entities:  

Keywords:  Belgium; Empirical Approach; Health Care and Public Health

Mesh:

Year:  1990        PMID: 2177298     DOI: 10.1080/17843286.1990.11718103

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  3 in total

1.  Screening for HIV during pregnancy. Survey of physicians' practices.

Authors:  S E MacDonald; L A Hartling; R M Seguin; K S O'Connor; M L Rekart; D L Mowat; J R Hoey
Journal:  Can Fam Physician       Date:  2001-11       Impact factor: 3.275

2.  Attitude towards serological tests for infection during pregnancy.

Authors:  G G Donders; J Desmyter; P Goubau; F A van Assche
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

3.  Optimizing the HIV/AIDS informed consent process in India.

Authors:  J Sastry; H Pisal; S Sutar; N Kapadia-Kundu; A Joshi; N Suryavanshi; K E Bharucha; A Shrotri; M A Phadke; R C Bollinger; A V Shankar
Journal:  BMC Med       Date:  2004-08-02       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.